Keyphrases
Head-and-neck Cancer
100%
Initial Treatment
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Treatment Change
100%
Lymph Node Ratio
100%
Viable Tumor
100%
Salvage Neck Dissection
100%
Radiotherapy
22%
Chemoradiation
22%
Radiotherapy Alone
22%
Neck Dissection
22%
Human Papillomavirus Negative
22%
Cancer Patients
11%
Retrospective Analysis
11%
Reduced Survival
11%
Predictive Factors
11%
Univariate Analysis
11%
Disease-specific
11%
5-fluorouracil (5-FU)
11%
Computed Tomography
11%
Carboplatin
11%
5-year Survival
11%
Watchful Waiting
11%
Cetuximab
11%
Systemic Therapy
11%
Enlarged Lymph Nodes
11%
Medicine and Dentistry
Neoplasm
100%
Head and Neck Cancer
100%
Lymph Node
100%
Neck Dissection
100%
Wart Virus
100%
Radiation Therapy
44%
Malignant Neoplasm
22%
Chemoradiotherapy
22%
Disease
11%
Cetuximab
11%
Predictive Factor
11%
Univariate Analysis
11%
Fluorouracil
11%
Lymphadenopathy
11%
Carboplatin
11%
Systemic Therapy
11%
Watchful Waiting
11%
Immunology and Microbiology
Neck
100%
Lymph Node
100%
Wart Virus
100%
X-Ray Computed Tomography
11%
Cetuximab
11%
Lymphadenopathy
11%